“As medical and pharmaceutical companies have gotten larger it’s become increasingly difficult to internally manage their R&D...60-70% of new pharma brought to market is licensed by other entities - on commercializing research. #medtech
Conversation
“We want to be able and ready partners for industry to partner with us...a tumultuous licensing process for example is a barrier to private sector partnerships - #medtech #healthtech